Changing the Landscape of Screening: AI-Powered ASMS Ligand Identification

Biography

Ghislaine Marchand leads the biophysics group at Evotec Toulouse, bringing over 25 years of expertise in the pharmaceutical industry. A trained pharmacist, she began her career at Sanofi, where she held various R&D positions spanning pharmacokinetics, anti-infective research and high-throughput screening. Since joining Evotec, Ghislaine has been at the forefront of biophysics innovation, overseeing a broad spectrum of technologies. Her team leverages key molecular interaction platforms such as surface plasmon resonance, microscale thermophoresis and differential scanning fluorimetry, alongside advanced mass spectrometry (MS)-based methods including affinity selection-MS, intact MS, peptide RapidFire-MS (RFMS), native MS and RFMS for both binding and functional assays. 

Biography

Benedikt Bauer leads a multidisciplinary data science group at Evotec Hamburg, driving the design and implementation of advanced analytics and machine learning models integrated into operational workflows. Since joining Evotec close to a decade ago, Benedikt has shaped various data related aspects of the company, from data management over data engineering to data science. His primary focus is on coordinating closely with biologists to identify scientific challenges where data science can deliver meaningful impact – bridging experimental insights with computational innovation.